Showing results (41-50 of 185) with videos related to

Sort By:
Pageof 19
Inflammatory Bowel Diseases|October 24, 2025
Cutaneous Manifestations and Dermatologic Adverse Events in IBD: A Clinical UpdateDimitrios Tsilimpotis, Georgia Kyriakou, Luc Biedermann, et al.
Digestion|January 9, 2020
Update on the Management of Inflammatory Bowel Disease during Pregnancy and BreastfeedingSophie Restellini, Luc Biedermann, Petr Hruz, et al.
BMC Gastroenterology|March 13, 2023
Lifestyle factors associated with inflammatory bowel disease: data from the Swiss IBD cohort studySeverin A Lautenschlager, Mamadou Pathé Barry, Gerhard Rogler, et al.
BMC Gastroenterology|May 6, 2025
Eosinophilic esophagitis patients report substantial disease burden comparable to more systemic immune-mediated diseasesEva Theswet, Chiara Brücker, Andrea Kreienbühl, et al.
Annals of Gastroenterology|November 29, 2023
Concomitant 5-aminosalicylic acid treatment does not affect 6-thioguanine nucleotide levels in patients with inflammatory bowel disease on thiopurinesRahel Looser, Michael Doulberis, Jean-Benoit Rossel, et al.
Annals of Neurology|July 12, 2002
Thrombolysis induces cerebral hemorrhage in a mouse model of cerebral amyloid angiopathyDavid T Winkler, Luc Biedermann, Markus Tolnay, et al.
Inflammatory Intestinal Diseases|February 3, 2025
Swallowed Topical Tacrolimus Induces Clinical and Histological Remission in a Subset of Patients with Severe Lymphocytic EsophagitisAlain Schoepfer, Sofia Asikainen, Luc Biedermann, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Long-term changes of bacterial and viral compositions in the intestine of a recovered Clostridium difficile patient after fecal microbiota transplantationFelix Broecker, Jochen Klumpp, Markus Schuppler, et al.
Case Reports in Gastroenterology|June 3, 2015
New Onset, Aggravation and Recurrence of Crohn's Disease upon Treatment with Three Different Tumor Necrosis Factor InhibitorsJonas Zeitz, Susann Enderlin, Luc Biedermann, et al.
Pageof 19